Position in ACLX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$9,793,456
+$4,450,708 QoQ
Shares Held
85,294
+4.1% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nuveen, LLC holds $4,556,892,459 across 227 Biotechnology names. ACLX ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,065,064 | $1,595,551,047 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,084,495 | $484,270,396 | |
| 3 | EXEL |
Exelixis, Inc.
|
3,782,734 | $162,241,460 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
322,232 | $106,616,900 | |
| 5 | INSM |
INSMED Inc
|
534,750 | $87,442,318 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
346,148 | $65,439,278 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
196,429 | $58,333,519 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
335,737 | $56,746,265 |
All Filings in ACLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,793,456 | 85,294 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $5,342,748 | 81,944 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $6,849,355 | 83,427 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,756,475 | 87,418 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $7,333,160 | 111,786 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||